Design Therapeutics Market Cap

Design Therapeutics has a market cap or net worth of $211.69 million as of April 26, 2024. Its market cap has decreased by -28.60% in one year.

Market Cap

211.69M

Enterprise Value

-67.78M

1-Year Change

-28.60%

Ranking

#3593

Market Cap Chart

Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $1.08B to $211.69M, a decrease of -80.33%. That is a compound annual growth rate of -40.97%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	212.40M	3.01%
Apr 24, 2024	206.20M	-0.29%
Apr 23, 2024	206.80M	-5.91%
Apr 22, 2024	219.80M	5.17%
Apr 19, 2024	209.00M	-1.09%
Apr 18, 2024	211.30M	-5.08%
Apr 17, 2024	222.60M	6.76%
Apr 16, 2024	208.50M	-2.62%
Apr 15, 2024	214.10M	2.69%
Apr 12, 2024	208.50M	-2.11%
Apr 11, 2024	213.00M	-0.79%
Apr 10, 2024	214.70M	1.90%
Apr 9, 2024	210.70M	-0.80%
Apr 8, 2024	212.40M	-
Apr 5, 2024	212.40M	5.62%
Apr 4, 2024	201.10M	-3.78%
Apr 3, 2024	209.00M	-4.39%
Apr 2, 2024	218.60M	-3.74%
Apr 1, 2024	227.10M	-0.26%
Mar 28, 2024	227.70M	3.08%
Mar 27, 2024	220.90M	9.52%
Mar 26, 2024	201.70M	-4.54%
Mar 25, 2024	211.30M	-1.58%
Mar 22, 2024	214.70M	16.56%
Mar 21, 2024	184.20M	12.45%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Accuray	217.18M
Lineage Cell Therapeutics	214.93M
Merrimack Pharmaceuticals	214.05M
Galectin Therapeutics	213.57M
Auna S.A.	211.80M
INmune Bio	211.12M
G1 Therapeutics	208.28M
Poseida Therapeutics	205.52M

Market Cap Rankings